Kura Oncology, Inc.KURANASDAQ

Revenue (LTM)

$67M

+25.2% YoY

Net Income (LTM)

$-279M

-60.2% YoY

Free Cash Flow

$-71M

Revenue CAGR (5Y)

—

—Marginsstable

FCFTurned negative

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	54	67↑25.2%
Gross Profit	0	0	-1	54↑6446.6%	67↑25.1%
Operating Income	-131	-140↓6.6%	-166↓18.5%	-193↓16.5%	-304↓57.2%
Net Income	-130	-136↓4.1%	-153↓12.4%	-174↓14.0%	-279↓60.2%
EBITDA	-129	-135↓4.1%	-150↓11.4%	-169↓12.8%	-304↓79.1%
EPS Diluted	-1.97	-2.03↓3.0%	-2.08↓2.5%	-2.02↑2.9%	-3.18↓57.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	91	52↓42.9%	37↓28.0%	224↑501.5%	149↓33.6%
Total Current Assets	522	446↓14.5%	432↓3.1%	745↑72.2%	709↓4.9%
Total Assets	534	456↓14.6%	449↓1.6%	760↑69.3%	738↓2.9%
Total Current Liabilities	22	24↑7.1%	35↑46.6%	79↑123.2%	117↑48.6%
Total Liabilities	27	36↑31.3%	52↑43.4%	347↑570.7%	564↑62.8%
Total Equity	507	420↓17.0%	397↓5.5%	414↑4.1%	174↓57.9%
Total Debt	7	14↑104.0%	17↑22.6%	17↓3.5%	20↑23.3%
Net Debt	-84	-38↑54.9%	-20↑46.7%	-208↓933.2%	-129↑38.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-105	-110↓5.3%	-125↓13.4%	134↑207.6%	-64↓147.7%
Capital Expenditure	-1	-1↑45.4%	-0↑73.2%	-0↓181.0%	-7↓1306.4%
Free Cash Flow	-106	-111↓4.7%	-125↓12.9%	134↑207.1%	-71↓152.8%
Stock-Based Comp	24	26↑11.6%	28↑6.7%	34↑20.7%	37↑9.5%
Net Change in Cash	-235	-39↑83.4%	-14↑62.7%	187↑1392.1%	-75↓140.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance